Dark
Light
System
Institutional Investment Manager
Cormorant Asset Management, LP
Cormorant Asset Management, LP (CIK: 0001583977) incorporated in Delaware, located at 200 Clarendon Street, Boston, MA. Institutional holdings reported to the SEC.

Institutional Holdings (2016Q2)
Portfolio Summary: 84 holdings with a total value of $705,177,000.
#
Name
Shares
Value ($)
%
Options
Notes
1 ALDER BIOPHARMACEUTICALS INC 1,689,071 42,176,000 5.98%
2 NEVRO CORP 491,044 36,219,000 5.14%
3 HERON THERAPEUTICS INC 1,771,263 31,971,000 4.53%
4 TESARO INC 362,875 30,500,000 4.33%
5 NEKTAR THERAPEUTICS COM 2,022,879 28,786,000 4.08%
6 MINERVA NEUROSCIENCES INC COM 2,800,000 28,588,000 4.05%
7 Theravance Biopharma Inc 1,118,372 25,376,000 3.60%
8 SAGE THERAPEUTICS 730,000 21,995,000 3.12%
9 EAGLE PHARMACEUTICALS INC COM 505,995 19,628,000 2.78%
10 MACROGENICS INC 707,978 19,108,000 2.71%
11 VITAE PHARMACEUTICALS INC 1,754,795 18,934,000 2.68%
12 GALAPAGOS NV 334,044 18,347,000 2.60%
13 NEUROCRINE BIOSCIE COM USD0.001 398,301 18,103,000 2.57%
14 OMEROS CORP 1,710,000 17,989,000 2.55%
15 ACLARIS THERAPEUTICS INC COM 901,286 16,647,000 2.36%
16 PROTEOSTASIS THERAPEUTICS IN 1,354,339 16,428,000 2.33%
17 Clearside Biomedical Inc 1,988,208 13,937,000 1.98%
18 CELLECTIS S A 498,117 13,245,000 1.88%
19 ARDELYX INC COM 1,499,226 13,088,000 1.86%
20 CHINA BIOLOGIC PRODS INC 112,867 12,000,000 1.70%
21 QUOTIENT LTD 1,537,717 11,917,000 1.69%
22 SORRENTO THERAPEUTICS INC COM NEW 2,121,013 11,878,000 1.68%
23 NOVAVAX INC COM 1,619,608 11,775,000 1.67%
24 ALNYLAM PHARMACEUTICALS INC 200,355 11,118,000 1.58%
25 COHERUS BIOSCIENCES INC COM 576,106 9,730,000 1.38%
26 MYOKARDIA INC 758,290 9,403,000 1.33%
27 PORTOLA PHARMACEUTICALS INC 396,000 9,346,000 1.33%
28 DYNAVAX TECHNOLOGIES CORP 635,000 9,258,000 1.31%
29 RELYPSA INC 450,000 8,325,000 1.18%
30 WAVE LIFE SCIENCES LTD 394,407 8,160,000 1.16%
31 SANGAMO BIOSCIENCES INCORPORATED 1,402,331 8,119,000 1.15%
32 DEXCOM 100,000 7,933,000 1.12%
33 ACHILLION PHARMACEUTICALS INC COM 1,006,128 7,848,000 1.11%
34 INC Research Holdings Inc 200,000 7,626,000 1.08%
35 SERES THERAPEUTICS INC 253,064 7,352,000 1.04%
36 ADVAXIS INC COM NEW 809,804 6,551,000 0.93%
37 AGENUS INC 1,578,106 6,391,000 0.91%
38 SOCIETAL CDMO INC 778,288 6,187,000 0.88%
39 FORWARD PHARMA A/S 339,175 6,163,000 0.87%
40 CORBUS PHARMACEUTICALS HLDGS COM 2,000,000 5,980,000 0.85%
41 ULTRAGENYX PHARMACEUTICAL INC COM 110,842 5,421,000 0.77%
42 COLLEGIUM PHARMACEUTICAL INC COM 455,515 5,398,000 0.77%
43 PFENEX INC COM 632,559 5,295,000 0.75%
44 DERMIRA INC 172,083 5,033,000 0.71%
45 ACCELERON PHARMA 127,451 4,331,000 0.61%
46 Agile Therapeutics, Inc. 563,880 4,291,000 0.61%
47 Atara Biotherapeutics Inc 186,460 4,197,000 0.60%
48 Lion Biotechnologies 505,941 4,098,000 0.58%
49 CYTOMX THERAPEUTICS INC COM 371,636 3,796,000 0.54%
50 Intec Pharma Ltd 809,804 3,724,000 0.53%
Page 1 of 2

Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-16-076682, filed 2016.08.15).

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.